Navigation Links
Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
Date:10/30/2007

cular Medicine, University of Leeds, U.K. at the National Cancer Research Institute Cancer Conference in Birmingham, U.K.

In this study, the investigators infected melanoma cell lines with reovirus. The reovirus-infected cell lines stimulated the maturation of dendritic cells, which in turn educated cancer-killing T cells to attack and kill the melanoma cells.

Manufacturing and Process Development

We continued to have REOLYSIN(R) manufactured in order to supply our current and future clinical trial program. In the third quarter of 2007, our manufacturing activity was focused on the completion of the vial filling and packaging of the production runs that were completed earlier in 2007. Also in the third quarter of 2007, we continued process development that examined the scale up of our manufacturing process increasing the batch size from our present GMP scale of 20-litres to 40-litres and then to 100-litres.

Intellectual Property

In the third quarter of 2007, two U.S. patents were issued. At the end of the third quarter of 2007, we had been issued over 150 patents including 23 U.S. and six Canadian patents as well as issuances in other jurisdictions. We also have over 180 patent applications filed in the U.S., Canada and other jurisdictions.

Financial Impact

We estimated at the beginning of 2007 that our monthly cash usage would be approximately $1,400,000 for 2007. Our cash usage for the nine months ending September 30, 2007 was $10,849,863 from operating activities and $635,815 for the purchases of intellectual property and capital assets which is in line with our estimate. Our net loss for the nine month period ending September 30, 2007 was $11,556,714.

Cash Resources

We exited the third quarter of 2007 with cash resources totaling $28,191,464 (see "Liquidity and Capital Resources").

Expected REOLYSIN(R) Development for the Remainder of 2007

We plan to continue to enroll patients in our seven clinic
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 CIRTEC Medical Systems, ... services for complex Class III implantable devices ... to develop a new 35,000 sq. ft. advanced ... has a long history of working with world’s ... breakthrough neurostimulation, heart assistance, drug delivery and smart ...
(Date:4/28/2015)... The Pistoia Alliance, a global, not-for-profit ... lower barriers to innovation in R&D, has announced the ... The Ontologies Mapping project has been set up to ... management in life sciences R&D. The project will see ... tools and services to enable the universal application of ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 According to ... than 450,000 patients receive medical treatment from burn injuries ... of burn injury, extensive formation of scars with subsequent ... burn patients for which there is no adequate treatment. ... prevent normal movement and can cause permanent deformity. ...
(Date:4/28/2015)... April 28, 2015 Reproductive endocrinologist Dr. ... in 7 couples battling infertility in this country, testified on ... Texas as the first state in the nation to consider ... embryos to couples who desire to receive them. , Infertility ... fact that infertility is one of the few medical diseases ...
Breaking Biology Technology:CIRTEC Medical Systems Expands Capacity with New Advanced Manufacturing Facility 2Pistoia Alliance Announces Start of Ontologies Mapping Project 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 3Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 2Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 3
... (Amex: CPD ) posted net sales for the ... $108.3 million, as compared to $35.4,million for the corresponding ... over the first quarter of Fiscal 2008. Pre-tax income ... 2009 as compared to a,pre-tax income of $9.6 million ...
... Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... call on Friday, August 8th at 8:30,AM ET, ... 2008. Insmed intends,to issue its quarterly financial results ... To participate in the live conference call, ...
... 24 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIFF), ... that the directors of MIGENIX Inc. have called ... held at 2:00 p.m. (Vancouver,time) on October 31, ... Vancouver,British Columbia. Further details with respect to the ...
Cached Biology Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed to Host Second Quarter 2008 Conference Call 2
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2
... (ret) Dale Meyerrose,Chief Information Officer, Office of the ... and Greg Garcia, Assistant Secretary for,Cybersecurity and Telecommunications, ... the Information Assurance community as the keynote,speaker. ... in the federal IA community has collaborated to,create ...
... this - IV (intravenous) lines in a sorghum ... one way that scientists at,the Texas Agricultural Experiment ... biofuel revolution. In Beaumont, Dr. Lee Tarpley, ... professor of crop physiology, have focused,their research on ...
... PITTSBURGH, September 12, 2007 A double amputee whose ... led to the development of new prosthetic innovations that ... the 13th annual Heinz Award for Technology, the Economy ... the world. Dr. Hugh Herr, 43, ...
Cached Biology News:Herr receives Heinz Award for Technology, the Economy and Employment 2Herr receives Heinz Award for Technology, the Economy and Employment 3Herr receives Heinz Award for Technology, the Economy and Employment 4
...
... The Polymerase gene from Thermus ... expressed in E. coli, then highly ... It is used in the amplification ... PCR. The quality of the Taq ...
Rabbit polyclonal to hnRNP-U...
... is a nonspecific endonuclease that degrades double-and ... hydrolyzing phosphodiester linkages, producing mono and oligonucleotides ... Ambion's RNase-free DNase I is of the ... degrade DNA in the presence of RNA ...
Biology Products: